MAGNETIC ISOLATION AND MOLECULAR ANALYSIS OF SINGLE CIRCULATING AND DISSEMINATED TUMOR CELLS ON CHIP
|
|
|
- Clifford Weaver
- 5 years ago
- Views:
Transcription
1 MAGNETIC ISOLATION AND MOLECULAR ANALYSIS OF SINGLE CIRCULATING AND DISSEMINATED TUMOR CELLS ON CHIP CRISTINA DE JONCHEERE LIESBET LAGAE, TIM STAKENBORG, CHENGXUN LIU MIRACLE (FP )
2 OVERVIEW Miracle aim Importance Challenge Miracle overview Market considerations 2
3 MIRACLE OVERVIEW Cell isolation with sieve Buffer reservoirs DNA detection Multiplex amplification AIM: A smart miniaturized system for the isolation, counting and molecular characterization of occult tumor cells directly from clinical samples. 3
4 IMPORTANCE IS CLEAR 13 Million cases of cancer worldwide 1 8 Million cancer related deaths 1 ~50% of cancer patients present with distant or local metastasis 2 Tumors shed approximately 1 million circulating tumor cells per gram of tumor tissue 2 1 AACR M. Campion, J. Voss, and K. Halling, 2011, Comunique 4
5 CIRCULATING TUMOR CELLS FOR CANCER DIAGNOSIS AND PROGNOSIS CTC in Breast Cancer Prediction of Recurrence (Giatromanolaki et al., 2004) Breast cancer tumor cells in blood has diagnostic and prognostic value BUT: Detection of rare tumor cells in circulation (few in 5 ml of blood) on routine basis is not straightforward 5
6 WHY USE CTCS? Biotech Industry Novel cancer markers Improved Cancer therapies Less toxic Better Prognosis Reduced mortality Less side effects Clinical evaluation Therapy response monitoring Automated Single Cell Capture & Molecular Analysis On chip For CTC identification User interface Data mining Patient Records Create awareness Promote acceptance Cancer society Clinicians Minimally invasive diagnosis Acurate Therapy Decision Reduced healthcare cost Patients User interface 6
7 THE CHALLENGE What defines a CTC? Here? 1 Tumor cell peripheral blood mononuclear cells 7
8 CURRENT APPROACHES FOR CTC DETECTION Nature Reviews Cancer 8, (May 2008) 8
9 CURRENT APPROACHES Circulating tumor cell separation system Immunomagnetic separation of Epcam positive cells using functionalized magnetic nanoparticles Microscopic evaluation of morphology Veridex, a J&J Problem: Only EpCAM company High throughput cell sorter (FACS) Single laser, single detector based sorting Moflo Beckman&Coulter Problem: Sensitivity 100,000 analysis events per second 9
10 MIRACLE OVERVIEW Key Challenges Using Clinical samples Assay robustness, sensitivity, specificity Flexibility towards downstream processing Use in hospital setting Key objective: Complete integrated platform Direct processing of clinical samples (blood & bone marrow) Single cell sensitivity (macro to micro interface) Multi-type assays (cell assay, RT- PCR and multiplex DNA amplification, DNA detection array) Hetero-integration (combining silicon & polymer technology) Continuous clinical evaluation / design / integration 10
11 MIRACLE OVERVIEW Immunomagnetic purification Cell isolation with sieve Cell sorting, counting & lysis Buffer reservoirs RT-PCR & DNA multiplex amplification DNA detection Multiplex amplification Hybridization Detection & read-out 11
12 MIRACLE OVERVIEW Probe immobilizatio n DNA hybridization HRP labeling and detection 12
13 MIRACLE OVERVIEW Clinical validation Microfluidic s Integrated circuits Molecular biology Nanoparticles 13
14 ADDRESSING A MEDICAL NEED Mammography Biopsy Surgery Relapse Pain Xray, CT Nothing is analyzed, no test exists!!! radiotherapy chemotherap y Death Therapy monitoring Companion diagnostics Time
15 SCIENTIFIC IMPACT (MIRACLE) Recent invited publication : Recent invited lectures : May 2010 (Dublin, Ireland) : Single Cell Analysis Congress Sept 2010 (Buenos-Aires, Argentina) : IEEE Engineering in Medicine and Biology Society Sept 2010 (Espoo, Finland) : Microfluidics in Bioanalytical Research and Diagnostics International Scientific Conference February 2011 (Leiden, the Netherlands) : Circulating Tumor Cell Isolation and Diagnostics... LET S KEEP IT THAT WAY 15
16 THE WORLD IS WATCHING 9/1/2010 EETimes Europe European project MIRACLE to deliver cancer diagnosis lab-on-chip system 9/1/2010 Leuven Inc. European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/7/2010 EETimes Asia Team research to develop lab-on-chip system vs cancer underway 9/2/2010 News Medical MIRACLE project to develop lab-on-chip system for diagnosing cancer 9/1/2010 Azonano imec Launches European Seventh Framework Project MIRACLE 9/6/2010 Elektronik & Data Lab-on-chip skal hjælpe cancerdiagnose 9/3/2010 Bionity.com en European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/3/2010 European Hospital Cheap and fast cancer diagnosis 9/6/2010 Bionity.com de "Lab-on-Chip" zur schnellen Krebsdiagnose: EU-Projekt MIRACLE wird von IMEC koordiniert 9/13/2010 Elektronik Informationen Lab-on-Chip zur schnellen Krebsdiagnose 9/2/2010 CORDIS Nachrichten MIRACLE-Projekt bringt Krebsbehandlung voran 9/2/2010 Elektronik Praxis Schnelle Krebsdiagnose mit "Lab-on-Chip" 9/2/2010 Tech Whack Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/8/2010 EETimes India Lab-on-chip system project to detect cancer cells takes off 9/3/2010 PC's Semiconductor Blog European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 CORDIS News MIRACLE project to advance cancer care 9/6/2010 EuroAlert.net MIRACLE's advanced LOC system, a step further towards better diagnosis of cancer 9/7/2010 Medical Device Network IMEC to Develop Lab-on-Chip Cancer Device 9/2/2010 Medi Lexicon European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 MTB Europe MIRACLE project launched to develop lab-on-chip for cancer diagnosis 9/2/2010 Medical News Today European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 Medical News Today Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/1/2010 Alpha Galileo European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Today's Healthy News Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 New Electronics Lab on chip research aims to accelerate detection of cancer 9/3/2010 Drug Discovery World Research To Develop Lab-on-chip System 9/1/2010 Electronic Specifier European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Semiconductor Packaging NewsLab-on-chip project aims to diagnose cancer faster 9/1/2010 Electro IQ (Small Times) Lab-on-chip project aims to diagnose cancer faster 9/1/2010 NanotechWire European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/1/2010 Nanowerk European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Med Tech Insider European Collaborative Research to Develop Lab-on-Chip System for Cancer Diagnosis 9/1/2010 PR ZOOM European Collaborative Research to Develop Lab-on-Chip System for Cheap and Fast Cancer Diagnosis 9/2/2010 Healthcare Technology Online imec European Collaborative Research To Develop Lab-On-Chip System For Cheap And Fast Cancer Diagnosis 9/2/2010 EETimes News & Analyses IMEC launches cancer lab-on-chip project 9/2/2010 Nanotechnology Now Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Genome Web Daily News European Collaboration Launches Effort to Develop Lab-on-Chip for Cancer Dx 9/2/2010 EDA Café Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/8/2010 Semiconductor Packaging NewsImec to develop lab-on-chip system for fast cancer diagnosis 9/1/2010 Newswire Today European Collaborative Research to Develop Lab-on-Chip System for Cheap and Fast Cancer Diagnosis 9/1/2010 HPC Wire Imec's European Collaborative Research to Develop Lab-on-Chip System for Cancer Diagnosis 9/2/2010 Opto IQ (Laser Focus World) European researchers team to develop lab-on-a-chip for cheaper cancer diagnosis 16
17 MARKET? Lead products Number of cases Number tests of Cost per test Market size USA World CTC prostate $300 $444M $11B CTC breast $300 $151M $3.6B CTC colon $300 $90M $2.6B CTC pancreas $300 $33M $792M Urine $50 $82M $2B Preclinical drug development $300 $30M $90M Clinical drug development $300 $40M $80M Total $870M $20B * Data from Dr. R.J. Cote, 42 nd annual oak ridge conference
18 HOW TO CAPITALIZE ON THIS MARKET? Selling Components Vs. Selling System Regulatory Requirements and Clinical Validation How to cater to all levels of the value chain, or which to prioritize? 18
19 ACKNOWLEDGEMENTS 19
Liquid biopsy, a new tool for cancer experts
Edition October 2017 Smart Health, Life sciences, CSR Liquid biopsy, a new tool for cancer experts More than 240 cancer specialists gathered in Leuven at the end of August to attend a symposium on liquid
CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS
CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM153A January 2014 Usha Nagavarapu Project Analyst ISBN: 1-56965-671-1 BCC Research 49 Walnut Park, Building 2 Wellesley, MA
Circulating Tumor Cells (CTC) Technologies
Table of Contents MIR036 I. SCOPE AND METHODOLOGY Scope of the Study Analytics and data presented in this report pertain to several parameters such as - Research Methodology This report is uniquely researched
Latest developments in Nanodiagnostics
Latest developments in Nanodiagnostics Dr Eric Mayes, CEO NANODIAGNOSTICS IN CANCER Why cancer? Second leading cause of death in noncommunicable disease Mechanisms of the disease are at the nanoscale First
The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer
Welcome! The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Prof. Sabine Kasimir-Bauer Department of Gynecology and Obstetrics University Hospital
Alere Technologies GmbH
Alere Technologies GmbH Mobile Smart Instruments for Automated Image Analysis and Point of Care Diagnosis April 2011 Alere Technologies GmbH Alere Technologies GmbH Based in Jena, Thuringia, Germany ~300
Prospective Clinical Study of Circulating Tumor Cells For Colorectal Cancer Screening
Prospective Clinical Study of Circulating Tumor Cells For Colorectal Cancer Screening Results From a Multi-Year 620-Sample Study CRC: SLOW GROWING, PREVENTABLE POLYP TO CANCER CAN TAKE 5 TO 15 YEARS CANCER
Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions
Radiation Oncology The conf ident path to treatment Philips Radiation Oncology Solutions The confident path to treatment Philips Radiation Oncology Solutions Imaging Image registration Contouring Treatment
Accelerate Your Research with Conversant Bio
Imagination has given us the steam engine, the telephone, the talkingmachine and the automobile, for these things had to be dreamed of before they became realities. So I believe that dreams... are likely
Survey Results Q1. How would you best describe your organization?
Survey Results Q1. How would you best describe your organization? Q2. How high would you rate the priority of Circulating Tumor Cells in you organization? Q3. What do you think is the biggest challenge
BBB_company Brief_2018
BBB_company Brief_2018 BBB Tech creates affordable blood-testing technologies with mobile-enabled tools and data insights. BBB History 2017. 11 Launched elemark TM dual check in Korea 2017. 08 Signed OEM
Disruptive innovation in molecular diagnostics. Hilde Windels CEO Biocartis 25 March 2017
Disruptive innovation in molecular diagnostics Hilde Windels CEO Biocartis 25 March 2017 1 One of the key innovations in healthcare in the last decade PERSONALISED MEDICINE or HIGH PRECISION MEDICINE From
Non-Invasive Array Based Screening for Cancer. Dr. Amit Kumar President and CEO CombiMatrix Corporation
Non-Invasive Array Based Screening for Cancer Dr. Amit Kumar President and CEO CombiMatrix Corporation www.combimatrix.com May 13, 2009 This presentation contains forward-looking statements within the
Update on Exact Sciences Molecular CRC Screening Test. November 16 th, 2011
Update on Exact Sciences Molecular CRC Screening Test November 16 th, 2011 0 Safe Harbor Statement Certain matters contained in this presentation, other than historical information, consist of forward-looking
Exosome DNA Extraction Kits
Exosome DNA Extraction Kits Summary Section 5 Introduction 40 EXO-DNAc 41 EXO-DNA 43 Introduction Genomic DNA Extractiom Kits Ordering informations Products can be purchased directly in our on-line shop:
30 years of progress in cancer research
Breast Cancer Molecular Knowledge Integrated in Clinical Practice Personalized Medicine Laura J. Esserman UCSF Comprehensive Cancer Center Retreat Breast Cancer Management Advances 80-90s 1) Screening
Jules Bordet Institute, Brussels, Belgium Université Libre de Bruxelles Breast International Group (BIG aisbl), Chair ESMO President
Symposium «Evaluation of the Belgian Cancer Plan» Brussels, November 26th, 2012 Personalized oncology in Europe: only a dream if national health systems do not get involved in diagnostics and pivotal cancer
Well-known victims of pancreatic cancer
Well-known victims of pancreatic cancer Luciano Pavarotti (1) diagnosed 2006, died 2007 Patrick Swayze (2) diagnosed 2008, died 2009 Steve Jobs (3) diagnosed 2004, died 2011 91% of pancreatic cancer patients
Joachim Eberle Head of R&D, Roche Centralized Diagnostics
Workshop Roche Diagnostics and Biomarker Development Joachim Eberle Head of R&D, Roche Centralized Diagnostics Biomarkers and Roche Making a Diagnostics test Current rograms 2 Why is Roche interested in
GLOBAL NEUROSTIMULATION MARKET
GLOBAL NEUROSTIMULATION MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d
Diagnosis of cancer in the UK, and how it might change in future
Diagnosis of cancer in the UK, and how it might change in future The UK has one of the poorest survival rates of cancer in Western Europe. Treatment given in UK NHS hospitals is possibly among the best
TESTIA For INNOVATIVE Solutions
TESTIA For INNOVATIVE Solutions 6 th Symposium for NDT in Aerospace Opening new ways in ndt using OMA communication system with Smart NDT Tool, UT & ET equipment Enhanced NDT by collaboration between mobile
A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications
A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications Yasuo Urata CEO and President Oncolys BioPharma Inc. February 16, 2013 Telomere Length is a Limiting Factor for Cell Replication
Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays
About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular
Decision Support in Radiation Therapy. Summary. Clinical Decision Support 8/2/2012. Overview of Clinical Decision Support
Decision Support in Radiation Therapy August 1, 2012 Yaorong Ge Wake Forest University Health Sciences Summary Overview of Clinical Decision Support Decision support for radiation therapy Introduction
High Sensitivity Immunomagnetic CTC Isolation as Compared to Alternative Isolation Methods
High Sensitivity Immunomagnetic CTC Isolation as Compared to Alternative Isolation Methods 1. Introduction: An overview of CTC isolation methods 2. Challenges for direct comparisons of CTC recovery 3.
Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc
1 Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc Safe Harbor Statement This presentation contains forward-looking statements within the meaning
TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal.
TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal. MISSION & VISION Our mission is to develop more effective strategies and safer products
Brochure More information from
Brochure More information from http://www.researchandmarkets.com/reports/2375238/ Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular
Background Information
Background Information Erlangen, November 26, 2017 RSNA 2017 in Chicago: South Building, Hall A, Booth 1937 Artificial intelligence: Transforming data into knowledge for better care Inspired by neural
Market surveillance of medical devices
Market surveillance of medical devices A joint action on market surveillance of medical devices to reinforce public health protection Information for healthcare professionals Introduction The European
The use of diagnostic FFPE material in cancer epidemiology research
The use of diagnostic FFPE material in cancer epidemiology research Neil O Callaghan Genetic Epidemiology Laboratory Department of Pathology The University of Melbourne www.pedigree.org.au Overview Who
What EU research policy can do for conditions such as chronic pain?
The EU Framework Programme for Research and Innovation HORIZON 2020 What EU research policy can do for conditions such as chronic pain? K Berkouk, PhD Deputy Head of Unit, Non-communicable diseases and
Challenges for use of CTCs as a Diagnostic. Farideh Z. Bischoff, Ph.D. Interim CSO Sr. Director, Translational Clinical Development Biocept, Inc.
Challenges for use of CTCs as a Diagnostic Farideh Z. ischoff, Ph.D. Interim CSO Sr. Director, Translational Clinical Development iocept, Inc. Current Technology for CTC Testing Existing CTC testing platform
By Sam Toppa BME 281 URI, Fall 2016
By Sam Toppa BME 281 URI, Fall 2016 Concussions and diagnostics A concussion is a mild traumatic brain injury (MTBI) caused by a blow to the head or whiplash; brain rebounds off the inner walls of skull.
Oncology Drug Development Using Molecular Pathology
Oncology Drug Development Using Molecular Pathology Introduction PRESENTERS Lee Schacter, PhD, MD, FACP Executive Medical Director, Oncology Clinipace Worldwide Martha Bonino Director, Strategic Accounts
Genomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
Bio Compatible Microsystem Packaging of VCSELaser for Implantable Devices
Bio Compatible Microsystem Packaging of VCSELaser for Implantable Devices Dr Alexander Steinecker, CSEM, Alpnach (CH) EPoSS Annual Forum, Torino (IT), 25.09.2014 Copyright 2014 CSEM Alexander Steinecker
MTC FoF Projects: - AMAZE - ENCOMPASS - OPENHYBRID. Dr. David Brackett Technology Manager Additive Manufacturing AMEF2016,
MTC FoF Projects: - AMAZE - ENCOMPASS - OPENHYBRID Dr. David Brackett Technology Manager Additive Manufacturing AMEF2016, 09-11-16 Additive Manufacturing Aiming Towards Zero Waste and Efficient Production
Novel Diagnostics and Biomarker Opportunities
1 Novel Diagnostics and Biomarker Opportunities LYMPHOMA EYE HEART BREAST COLON BLADDER CERVIX PROSTATE From research to business Inven2 transforms science and technology into useful and profitable products
Early dissemination in prostate cancer
Early dissemination in prostate cancer Miodrag Guzvic, University of Regensburg, Germany Adjuvant Palliative M0 Initiation Diagnosis Surgery Metastasis Death Intervention window to delay or prevent metastasis
Rapid Point-of-Care Tests for STIs: needs, progress, challenges
Rapid Point-of-Care Tests for STIs: needs, progress, challenges Ranmini Kularatne Centre for HIV and STIs National Institute for Communicable Diseases National Health Laboratory Service South Africa Nov
UK X-FEL National Laboratory Perspective
UK X-FEL National Laboratory Perspective Susan Smith STFC ASTeC IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Content Overview STFC national labs capabilities FEL R&D Underpinning accelerator
Optical cochlear implant project
Optical cochlear implant project Dr.-Ing. Stefan Mohrdiek MNBS 2014 LAAS, Toulouse 21 & 22 October 2014 This project is supported by the EU Commission, the European Research Funding organization under
Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018
Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018 Summary: This document follows on from the findings of the CM-Path The
SU2C TOP SCIENCE ACCOMPLISHMENTS
SU2C TOP SCIENCE ACCOMPLISHMENTS INTRODUCTION Since our founding in 2008, Stand Up To Cancer has funded 87 team science projects, with budgets ranging from $250,000 for a short research project to over
Infrastructure for Rapid Assessment of Reliability
Infrastructure for Rapid Assessment of Reliability Infrastructure and process improvements in the reliability testing of a high density microelectronic packaging technology Hannah Varner Draper Outline
Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts
Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts NuSep (ASX:NSP) key facts No. shares 237,606,002 Market Cap. $7.1 million (@3 cps) No. of shareholders Approx.
Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research
Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to 2024 - Hexa Research " The global ultrasound device market was valued at approximately USD 6.8 billion and it is projected
DELIVERABLE REPORT. Grant Agreement number:
Laser and Ultrasound Co-Analyzer for thyroid nodules DELIVERABLE REPORT Grant Agreement number: 688303 Project acronym: LUCA Project title: Laser and Ultrasound Co-Analyzer for thyroid nodules Funding
numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics
numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics Three benefits of numares 1 Supporting patients to receive better cure based on effective
INTRODUCTION PREVIOUSLY FUNDED PROJECTS
INTRODUCTION Each year in the United States, more than 1.6 million people are diagnosed with cancer and more than half a million die from this terrible disease. And each year, our researchers spend thousands
Neoplasia 2018 lecture 11. Dr H Awad FRCPath
Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even
National Academies Next Generation SAMPLE Researchers TITLE Initiative HERE
National Academies Next Generation SAMPLE Researchers TITLE Initiative HERE Dennis A. Dean, II, PhD Sanofi Auditorium July 13, 2017 sevenbridges.com A little about me Research Experience Analytics and
Noninvasive Glucose Monitors to 2022
Noninvasive Glucose Monitors to 2022 Devices, Technologies, Players and Prospects Report Prospectus Greystone Research associates N o n i n v a s i v e G l u c o s e M o n i t o r s t o 2 0 2 2 Greystone
CyBio Felix Your Automated Application Starts Here
Title Label Lab Automation CyBio Felix Your Automated Application Starts Here 2 CyBio FeliX Future-Proof Liquid Handling Automation Transform your manual workflows to automated processes on your benchtop!
Corporate Presentation Fourth Quarter 2017
Corporate Presentation Fourth Quarter 2017 November 2017 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD
Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review
Molecular Diagnostic Solutions for Urologic Cancer
1 Molecular Diagnostic Solutions for Urologic Cancer 2017 First Half Results Presented on 31 August 2017 Dr. Jan Groen, President & CEO Mr. Jean-Marc Roelandt, EVP & CFO 2 Forward looking statement This
Lynch Syndrome and COLARIS Testing
Lynch Syndrome and COLARIS Testing Webinar Objectives Review of Lynch syndrome as a multi-gene disorder COLARIS Enhancements Technical Overview COLARIS test offerings Test development and validation process
Personalised Healthcare. will it deliver? Bob Holland Head of Personalised Healthcare & Biomarkers Innovative Medicines AstraZeneca R&D
Personalised Healthcare x will it deliver? Bob Holland Head of Personalised Healthcare & Biomarkers Innovative Medicines AstraZeneca R&D Personalised Healthcare It is delivering! Bob Holland Head of Personalised
Potential Opportunities for Collaboration with Pancreatic U01s
Potential Opportunities for Collaboration with Pancreatic U01s Sudhir Srivastava, PhD, MPH Chief, Cancer Biomarkers Research Group Division of Cancer Prevention Background Recalcitrant Cancer Research
Data Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist
Data Harmonization Efforts Across the Cancer Staging System Donna M. Gress, RHIT, CTR AJCC Technical Specialist Objectives Describe efforts underway to harmonize data elements and concepts used in cancer
AdnaNews. News from the meeting on Advances in Circulating Tumor Cells (ACTC), Reythymnon, Crete, Greece October 8-11, 2014.
News from the meeting on Advances in Circulating Tumor Cells (ACTC), Reythymnon, Crete, Greece October 8-11, 2014. The ACTC meeting (www.actc2014.org) is together with the ISMRC meeting one of the most
Digital Microscopy and Diagnosis on Cellphones
Digital Microscopy and Diagnosis on Cellphones Aydogan Ozcan Electrical Engineering Department Bioengineering Department California NanoSystems Institute University of California, Los Angeles ozcan@ucla.edu
Top Performance in Action. Never confuse movement with action Ernest Hemingway
Top Performance in Action Never confuse movement with action Ernest Hemingway Improved imaging in difficult to scan patients Major technical improvements provided by CrystaLine include the CPI Technology
Microfluidic chip-based diagnostics of cervical cancer
Microfluidic chip-based diagnostics of cervical cancer Liv Furuberg Chief Scientist, SINTEF Michal Mielnik, Ib-Rune Johansen, Anja Gulliksen, Lars Solli, Tobias Baier, Thomas Hansen-Hagge, Rainer Gransee,
Flow Cytometry Core Facility
Flow Cytometry Core Facility cell analysis & cell sorting Carolyn O Connor Director, Flow Cytometry Core Facility Salk.edu/fccf coconnor@salk.edu S A L K I N S T I T U T E F O R B I O L O G I C A L S T
Innovations in Lung Cancer Treatment and Research CPAT Seminar June 11, 2014 Scott Santarella, President Bonnie J. Addario Lung Cancer Foundation
Innovations in Lung Cancer Treatment and Research CPAT Seminar June 11, 2014 Scott Santarella, President Bonnie J. Addario Lung Cancer Foundation BONNIE J. ADDARIO LUNG CANCER FOUNDATION (ALCF) How We
Future of Diabetes Research in Europe JDRF Perspective
Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended
Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
Catalyzing the Next Generation of Cancer Technologies
Catalyzing the Next Generation of Cancer Technologies Presentation to the IOM Workshop on the Cures Acceleration Network June 4, 2012 Michael Weingarten Director, NCI SBIR Development Center Today s Presentation
Validation of QClamp as Next Generation Liquid Biopsy Technique for Colorectal Cancer He James Zhu M.D. Ph.D
Validation of QClamp as Next Generation Liquid Biopsy Technique for Colorectal Cancer He James Zhu M.D. Ph.D Department of Radiation Oncology University of Florida College of Medicine Outline Objective
Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast
Report Information More information from: https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeuticsmarket-research Global Skin Cancer Diagnosis and Therapeutics Market
7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES
7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES 13-14 June 2018 Dublin, Ireland WHY Since the Avoca Quality Consortium (AQC) launched seven years ago, its mission and purpose has been to
Liquid Biopsies. Next Generation Cancer Molecular Diagnostics
Liquid Biopsies Next Generation Cancer Molecular Diagnostics Forward Looking Statements 2 Statements pertaining to future financial and/or operating results, future research, diagnostic tests and technology
BORDET DEPARTMENT RADIATION ONCOLOGY
BORDET DEPARTMENT RADIATION ONCOLOGY The Radiation Oncology Department has been providing patients with high quality, tailored radiation oncology care for the last 60 years in a multidisciplinary setting
MARCH 2017 RESEARCH REPORT
1 MARCH 2017 RESEARCH REPORT LIQUID BIOPSY MARKETS by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides Liquid Biopsy
Product Overview CELL-FREE DNA BCT CELL-FREE RNA BCT CELL-FREE DNA URINE PRESERVE CYTO-CHEX BCT STRECK CELL PRESERVATIVE
FIXED ON INTEGRITY Product Overview CELL-FREE DNA BCT A blood collection tube for stabilization of cell-free plasma DNA, CTCs and cellular DNA. The preservative in Cell-Free DNA BCT stabilizes nucleated
Managing & Aligning Lists of Chemicals of High Concern
Managing & Aligning Lists of Chemicals of High Concern Ivan Welvaert Director, Global Product Stewardship Office of Global Sustainability December, 2017 Boston, US 2017 BD. BD, the BD Logo and all other
The Avatar System TM Yields Biologically Relevant Results
Application Note The Avatar System TM Yields Biologically Relevant Results Liquid biopsies stand to revolutionize the cancer field, enabling early detection and noninvasive monitoring of tumors. In the
MammaPrint Improving treatment decisions in breast cancer Support and Involvement of EU
MammaPrint Improving treatment decisions in breast cancer Support and Involvement of EU 1 Bas van der Baan VP Clinical Affairs Irvine, California Amsterdam, The Netherlands 2 Two Crucial Questions in Cancer
Youngnam Cho. National Cancer Center Biomarker Branch
Youngnam Cho National Cancer Center Biomarker Branch Contents 1. Liquid Biopsy 2. Circulating Tumor Cells from Blood 3. Cell-free DNA from Blood 1. Liquid biopsy Cancer Diagnosis IMAGING TISSUE BIOPSY
Extracellular Vesicle RNA isolation Kits
Extracellular Vesicle RNA isolation Kits Summary Section 4 Introduction 42 Exo-TotalRNA and TumorExo-TotalRNA isolation kits 43 Extracellular Vesicle RNA extraction kits Ordering information Products can
Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim
Circulating tumor cells/dna/etc for Radiation Oncologists
Circulating tumor cells/dna/etc for Radiation Oncologists Andrew Z. Wang, M.D. Associate Professor Director of Clinical and Translational Research Department of Radiation Oncology Carolina Center for Cancer
Challenges and Opportunities for In Vivo Imaging in Oncology
Challenges and Opportunities for In Vivo Imaging in Oncology Daniel C. Sullivan, M.D. Unraveling of the genome and proteome, and advances in biomedical technology are changing the practice of medicine
Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research
Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to 2024 - Hexa Research " The global hypodermic needles market was estimated at USD 2,568.7 million in 2016. The primary
IRESSA (Gefitinib) The Journey. Anne De Bock Portfolio Leader, Oncology/Infection European Regulatory Affairs AstraZeneca
IRESSA (Gefitinib) The Journey Anne De Bock Portfolio Leader, Oncology/Infection European Regulatory Affairs AstraZeneca Overview The Drug The Biomarker and Clinical Trials Sampling Lessons Learned The
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
Staging for Residents, Nurses, and Multidisciplinary Health Care Team
Staging for Residents, Nurses, and Multidisciplinary Health Care Team Donna M. Gress, RHIT, CTR Validating science. Improving patient care. Learning Objectives Introduce the concept and history of stage
Artificial Intelligence AI for Smarter Healthcare
Artificial Intelligence AI for Smarter Healthcare What is Artificial Intelligence? What is Artificial Intelligence? Artificial Intelligence is a way of making a computer, a computer-controlled robot,
GENReports: Market & Tech Analysis
GENReports: Market & Tech Analysis > Gary Oosta, Ph.D. Biotechnology Analyst, Select Biosciences, Inc. > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Twitter: @enalrazvi
GE Healthcare 9900 Innovation Drive Wauwatosa, WI U.S.A.
2011 General Electric Company All rights reserved. General Electric Company reserves the right to make changes in specifications and features shown herein, or discontinue the product described at any time
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,
1.5. Research Areas Treatment Selection
1.5. Research Areas Cancer biomarker research embraces many areas of study, including tumorigenesis, metastasis, clinical trial and surrogate endpoints, cell isolation, target identification, drug resistance,
Monique J. Roobol. Active Surveillance: update on Initiatives
Monique J. Roobol Associate professor Dept. of Urology Erasmus University Medical Center Rotterdam, the Netherlands Active Surveillance: update on Initiatives Overview Studies on Active Surveillance world
Integrated platform for liquid biopsy-based personalized cancer medicine
Integrated platform for liquid biopsy-based personalized cancer medicine Dr. Bernhard Polzer Fraunhofer ITEM-Regensburg Personalized Tumor Therapy Personalized cancer therapy Primary tumor single tumor